(Q44483887)

English

Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer (English)

1 reference

Europe PubMed Central

3 December 2017

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jun-Yang Lu

1

1 reference

Europe PubMed Central

3 December 2017

Yi Xiao

2

1 reference

Europe PubMed Central

3 December 2017

Hui-Zhong Qiu

3

1 reference

Europe PubMed Central

3 December 2017

Bin Wu

4

1 reference

Europe PubMed Central

3 December 2017

Guo-Le Lin

5

1 reference

Europe PubMed Central

3 December 2017

Lai Xu

6

1 reference

Europe PubMed Central

3 December 2017

Guan-Nan Zhang

7

1 reference

Europe PubMed Central

3 December 2017

Ke Hu

8

1 reference

Europe PubMed Central

3 December 2017

publication date

1 August 2013

1 reference

Europe PubMed Central

3 December 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

3 December 2017

108

1 reference

Europe PubMed Central

3 December 2017

4

1 reference

Europe PubMed Central

3 December 2017

213-219

1 reference

Europe PubMed Central

3 December 2017

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Systemic therapy for metastatic colorectal cancer: current options, current evidence

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Anterior Perineal PlanE for Ultra-low Anterior Resection of the Rectum (the APPEAR technique): a prospective clinical trial of a new procedure

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23394

21 January 2018

Identifiers

10.1002/JSO.23394

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44483887&oldid=2025523405"